عاجل
Newsgather

PTSD

مستقر13 خبر7 مصادرآخر تحديث: 3 g önce

أحدث الأخبار

يتطور
صحة·25.05.2026ملخص الذكاء الاصطناعي

Australia's Psychedelic Medicine Boom: MDMA and Psilocybin Therapy for PTSD and Depression

Australia is pioneering psychedelic medicine, with licensed facilities manufacturing MDMA for PTSD and psilocybin for depression. Patients like Jess Yugovich report life-changing therapeutic benefits, though experts caution about costs and suitability, emphasizing the distinction between regulated medical use and illicit street drugs.

A
ABC Top Stories
馬英九晚年風波引發世代PTSD,作者細數其政治生涯爭議
يتطور
سياسة·24.05.2026ملخص الذكاء الاصطناعي

馬英九晚年風波引發世代PTSD,作者細數其政治生涯爭議

前總統馬英九近期因醫療照護聲明引發與妻姐的晚年風波,作者藉此細數馬英九從台北市長到總統任內的多項爭議事件,包括納莉風災、和平醫院封院、八八風災、633承諾跳票、22K方案、油電雙漲、兩兆雙星計畫、關廠工人案、大巨蛋案、馬王政爭、外交休兵、馬習會及太陽花學運等,認為其政治生涯充滿爭議,對1980年代出生的世代造成「PTSD」。

自由时报
馬英九晚年風波引發世代PTSD,作者細數其政治生涯爭議
يتطور
سياسة·24.05.2026ملخص الذكاء الاصطناعي

馬英九晚年風波引發世代PTSD,作者細數其政治生涯爭議

前總統馬英九近期與妻姐周美青、馬以南因醫療照護聲明引發爭議。本文作者張家哲藉此回顧馬英九從台北市長到總統任內的諸多爭議事件,包括納莉風災、和平醫院封院、八八風災、633承諾跳票、22K方案、油電雙漲、兩兆雙星計畫失敗、關廠工人案、大巨蛋案、馬王政爭、外交休兵、馬習會及太陽花學運等,認為這些事件對1980年代出生的台灣人造成「PTSD」,並質疑馬英九的執政模式。

自由时报
Veteran Finds Healing Through Bourbon Tasting as 'Taste Mindfulness'
صحة
30.04.2026ملخص الذكاء الاصطناعي

Veteran Finds Healing Through Bourbon Tasting as 'Taste Mindfulness'

Fred Minnick, an Iraq War veteran with PTSD, discovered healing through bourbon tasting as a form of mindfulness therapy. After returning from deployment in 2004-2005, he struggled with anger and anxiety until his VA therapist suggested using his love of food and flavors as a meditative practice. He now teaches "taste mindfulness" workshops and has written eight books about bourbon, including a recent one about his journey home from war that has resonated with fellow veterans.

N
NPR News
FDA Announces Measures to Accelerate Psychedelic Treatments for Mental Illness
يتطور
صحة·24.04.2026ملخص الذكاء الاصطناعي

FDA Announces Measures to Accelerate Psychedelic Treatments for Mental Illness

The FDA announced measures to accelerate psychedelic treatments for serious mental illness, following President Trump's executive order expanding access to emerging therapies. The agency will issue priority vouchers for psilocybin research for depression and methylone for PTSD, and cleared the first U.S. clinical trial of noribogaine hydrochloride for alcohol use disorder.

C
CNBC